It's almost 3 p.m. ET on the East Coast and noon on the West Coast. If you're just joining us, here are the latest developments on the coronavirus pandemic in the US:
- Covid-19 cases increase in Tulsa ahead of rally: The number of coronavirus cases are increasing in Tulsa, Oklahoma, ahead of President Trump's campaign rally on Saturday. Ninety-six Tulsa residents tested positive for Covid-19 in the past day, according to Dr. Bruce Dart of the Tulsa Health Department. This is a new daily record for the county, Dart said.
- Schools allowed to resume in Michigan: Schools across Michigan will be allowed to resume in-person instruction this fall with strict safety measures in place, Gov. Gretchen Whitmer announced. The governor will release an executive order and the "Michigan Return to School Roadmap" on June 30 to outline details on what will be required and recommended for schools to reopen.
- New York City to enter phase two of reopening: Phase two allows for a wider range of businesses to continue to reopen under Covid-19 guidelines, including retail businesses and offices, according to the state's reopening website. New York City Mayor Bill de Blasio has announced that once the city enters phase two, restaurants will be able to open for outdoor seating, and convert parking spaces into seating areas.
- Nation's top infectious disease expert's advice for the MLB: Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said baseball season should not extend past October to avoid the risk of spreading Covid-19. In an interview with the Los Angeles Times on Tuesday, Fauci said Major League Baseball (MLB) should conclude the postseason in September over concerns of a second coronavirus wave in the fall.
- WHO ends portion of trial: The hydroxychloroquine arm of the World Health Organization’s Covid-19 Solidarity Trial will end based on a recommendation from the agency’s Data Safety and Monitoring Committee, according to a WHO official. The decision was made based on preliminary information from a separate hydroxychloroquine study in the United Kingdom that showed no benefit of the antimalarial against Covid-19, and early data from the Solidarity Trial itself, WHO said.